# Gynecomastia Extension Study

> **NCT00637182** · PHASE3 · COMPLETED · sponsor: **AstraZeneca**

## Conditions studied

- Gynecomastia

## Interventions

- **DRUG:** Anastrozole

## Key facts

- **NCT ID:** NCT00637182
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2002-06
- **Final completion:** 2002-10
- **Target enrollment:** — (—)
- **Last updated:** 2008-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637182, "Gynecomastia Extension Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00637182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*